NASDAQ: COYA
Coya Therapeutics Inc Stock Ownership - Who owns Coya Therapeutics?

Insider buying vs selling

Have Coya Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David S. SnyderChief Financial Officer2024-11-141,800$7.19
$12.93kBuy
Arun SwaminathanChief Executive Officer2024-11-135,000$7.36
$36.80kBuy
Fred GrossmanChief Medical Officer2024-11-112,710$7.37
$19.97kBuy
Arun SwaminathanChief Executive Officer2024-11-115,000$7.34
$36.69kBuy

1 of 1

COYA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COYA insiders and whales buy or sell their stock.

COYA Shareholders

What type of owners hold Coya Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aigh Capital Management LLC6.61%1,105,622$6.29MInstitution
Howard Berman5.68%949,338$5.40MInsider
Bertex LLC5.62%939,338$5.34MInsider
Vanguard Group Inc5.03%840,471$4.78MInstitution
CM Management LLC1.20%200,000$1.14MInstitution
Wilbur L. Ross Jr.0.99%165,016$938.12kInsider
Geode Capital Management LLC0.94%157,087$893.04kInstitution
Blackrock Inc0.41%68,256$388.04kInstitution
Northern Trust Corp0.24%39,376$223.85kInstitution
Ann Lee0.20%33,958$193.05kInsider

1 of 3

COYA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COYA15.13%12.80%Net Buying
DOMH5.49%58.27%
ADAG0.42%0.00%
ANIX10.93%84.61%Net BuyingNet Buying
IVVD23.88%76.12%Net Selling

Coya Therapeutics Stock Ownership FAQ

Who owns Coya Therapeutics?

Coya Therapeutics (NASDAQ: COYA) is owned by 15.13% institutional shareholders, 12.80% Coya Therapeutics insiders, and 72.07% retail investors. Howard Berman is the largest individual Coya Therapeutics shareholder, owning 949,338.00 shares representing 5.68% of the company. Howard Berman's Coya Therapeutics shares are currently valued at $5.40M.

If you're new to stock investing, here's how to buy Coya Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.